SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-017875
Filing Date
2019-11-19
Accepted
2019-11-18 19:17:04
Documents
2
Period of Report
2019-11-18
Effectiveness Date
2019-11-19

Document Format Files

Seq Description Document Type Size
1 def14-a.htm DEF 14A 214676
2 px_001.jpg GRAPHIC 170850
  Complete submission text file 0001493152-19-017875.txt   451226
Mailing Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334
Business Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334 972-72-2608004
OWC Pharmaceutical Research Corp. (Filer) CIK: 0001431934 (see all company filings)

IRS No.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-54856 | Film No.: 191228764
SIC: 3841 Surgical & Medical Instruments & Apparatus